Fmoc-PNA-G(Bhoc)-OH>98.0%(HPLC)(qNMR)1g

4'-Chloro-2',6'-difluoroacetophenone, 95.0%, 500mg

Methyl (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate, 95%, 250mg

5-tert-Butyl 3-ethyl 6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-3,5(4H)-dicarboxylate, 95.0%, 10g

1-tert-Butoxy-4-chlorobenzene>95.0%(GC)25g

tert-Butyl 5-methyl-2,7-diazaspiro[3.5]nonane-7-carboxylate hydrochloride, 97%, 5g

1-Cyclopentyl-1H-pyrrole-2,5-dione, 95.0%, 500mg

Recipientes de evaporación 109, 75 ml, 0, 10 Pieza(s)

[2-(Methylsulfanyl)-1,3-benzothiazol-6-yl]boronic acid, 98%, 100mg

1-(benzo[d]thiazol-2-yl)azetidin-3-ol, 95.0%, 10g

Homogeneizador Duall, 5 ml 1 pieza

5-Acetyl-2-methoxypyridine>98.0%(GC)1g

Dispensadores FORTUNA® OPTIFIX® SOLVENT, 100–500 ml, 1 pieza